【24h】

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

机译:术前中性粒细胞与淋巴细胞的比例作为肝癌根治性切除后的预后指标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: This study was designed to evaluate the impact of an elevated preoperative neutrophil-to-lymphocyte ratio (NLR) on outcome after curative resection for hepatocellular carcinoma (HCC). METHODS: Patients undergoing resection for HCC from January 1994 to May 2007 were identified from the hepatobiliary database. Demographics, laboratory analyses, and histopathology data were analyzed. RESULTS: A total of 96 patients were identified with a median age at diagnosis of 65 (range, 15-85) years. The 1-, 3-, and 5-year overall survival rates were 80%, 58%, and 52%, respectively. Although the presence of microvascular invasion, NLR >or=5, and R1 resection margin were adverse predictors of overall survival, there were no independent predictors identified on multivariate analysis. The 1-, 3-, and 5-year disease-free survival rates were 74%, 63%, and 57%, respectively. Preoperative tumor biopsy, NLR >or= 5, multiple liver tumors, microvascular invasion, and R1 resection margin were all predictors of poorer disease-free survival. Multivariate analysis showed that a NLR >or= 5 and R1 resection margin were independent predictors of poorer disease-free survival. The median disease-free survival of those with a NLR >or= 5 was 8 months compared with 18 months for those with a NLR < 5. CONCLUSION: Preoperative NLR >or= 5 was an adverse predictor of disease-free and overall survival.
机译:背景:本研究旨在评估术前中性粒细胞与淋巴细胞比率(NLR)升高对肝癌(HCC)根治性切除术后预后的影响。方法:从肝胆数据库中识别1994年1月至2007年5月接受肝癌切除的患者。人口统计学,实验室分析和组织病理学数据进行了分析。结果:总共鉴定出96名患者,诊断中位年龄为65岁(范围15-85)。 1年,3年和5年总生存率分别为80%,58%和52%。尽管存在微血管浸润,NLR>或= 5和R1切除切缘是总体生存率的不利指标,但在多变量分析中没有发现独立的指标。 1年,3年和5年无病生存率分别为74%,63%和57%。术前肿瘤活检,NLR>或= 5,多发性肝肿瘤,微血管浸润和R1切除切缘都是无病生存期较差的预测指标。多变量分析显示,NLR>或= 5和R1切除切缘是无病生存期较差的独立预测因素。 NLR>或= 5的患者中位无病生存期为8个月,而NLR <5的患者中位无病生存期为18个月。结论:术前NLR>或= 5是无病生存期和总生存期的不利指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号